Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 30.5% | +3.9 pp | +188.4 pp | |
| LTM Mar 2026 | 25.2% | +93.4 pp | +1052.7 pp | |
| LTM Sep 2026 | -309.5% | — | — | |
| LTM Mar 2026 | -843.9% | -542.0 pp | -540.2 pp | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -5986.3% | -3970.2 pp | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
ORKAOruka Therapeutics, Inc. | FY2025 | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ODTX) | -309.5% | -269.0 pp | +188.4 pp | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.